Organon (OGN) Gross Margin (2020 - 2026)
Organon (OGN) posted quarterly Gross Margin of 53.63% for Q1 2026, down 195.0% year-over-year from 56.45% in Q1 2025, and up 9.07% on a QoQ basis from 49.17% in Q4 2025.
Organon (OGN) Gross Margin (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Gross Margin for 7 consecutive years, with 53.63% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 195.0% year-over-year to 53.63%; the TTM figure through Mar 2026 stood at 52.82% (down 437.0% YoY), while the FY2025 annual figure was 53.3%, down 472.0% from the prior year.
- Gross Margin came in at 53.63% for Q1 2026 at Organon, up from 49.17% in the prior quarter.
- The five-year high for Gross Margin was 64.2% in Q1 2022, with the low at 49.17% in Q4 2025.
- Average Gross Margin over 5 years is 58.2%, with a median of 58.43% recorded in 2024.
- Across the five-year window, Gross Margin jumped 344 bps in 2022 and slumped 711 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 60.0% in 2022, then slipped by 5 bps to 57.26% in 2023, then declined by 2 bps to 56.28% in 2024, then declined by 13 bps to 49.17% in 2025, then advanced by 9 bps to 53.63% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 53.63%, 49.17%, and 53.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 81.93% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 66.31% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 71.88% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 87.65% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 74.24% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 68.16% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 79.24% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -51.69% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 53.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.63% |
| Dec 31, 2025 | 49.17% |
| Sep 30, 2025 | 53.50% |
| Jun 30, 2025 | 54.83% |
| Mar 31, 2025 | 55.58% |
| Dec 31, 2024 | 56.28% |
| Sep 30, 2024 | 58.34% |
| Jun 30, 2024 | 58.43% |
| Mar 31, 2024 | 59.00% |
| Dec 31, 2023 | 57.26% |
| Sep 30, 2023 | 59.71% |
| Jun 30, 2023 | 60.20% |
| Mar 31, 2023 | 62.29% |
| Dec 31, 2022 | 60.00% |
| Sep 30, 2022 | 64.15% |
| Jun 30, 2022 | 62.90% |
| Mar 31, 2022 | 64.20% |
| Dec 31, 2021 | 62.63% |
| Sep 30, 2021 | 61.94% |
| Jun 30, 2021 | 63.45% |